Mr. HAU Wai Man, Raymond, aged 48, is the Chief Financial Officer, Qualified Accountant, Company Secretary and director of several subsidiaries of the Company. He is a fellow member of the Association of Chartered Certified Accountants (ACCA), a member of Hong Kong Institute of Certified Public Accountants (HKICPA) and a Chartered Financial Analyst (CFA) Charterholder. He holds an MBA degree from The Hong Kong University of Science and Technology (HKUST), and has over 10 years of experience in international accounting firms and corporates in Hong Kong and the PRC before joining the Company in 2006.

Ms. DONG Yu, aged 41, is the director and chief executive officer of Hangzhou Meerkat Health Technology Co., Ltd., a subsidiary of the Group. Ms. DONG graduated from Tianjin University of Technology with a Bachelor’s degree in Chemical Engineering and Technology. Prior to joining the Group in July 2021, Ms. DONG worked for Alibaba Group Holding Limited (‘‘Alibaba’’, NYSE: BABA; HKEX: 9988) and Alibaba Health Information Technology Limited (‘‘Alibaba Health’’, HKEX: 241) for nearly 15 years and was responsible for the establishment of their medical and healthcare services businesses. She possesses extensive experiences and networks in the realms of pharmaceutical and medical care services via the Internet in the PRC, especially focusing on the field of medical and healthcare services. Ms. DONG has held various key positions including head of medical and healthcare services business division, head of the PRC government relations department in charge of major projects and activities cooperated with governments, and sales planning manager of B2B business division, accumulating extensive experience in the fields of product research and design, e-commerce operation, marketing operation and strategic planning. Ms. DONG also serves as director of several subsidiaries of the Company.

Mr. LIU Feng, aged 41, is the chief technology officer of Hangzhou Meerkat Health Technology Co., Ltd., a subsidiary of the Group. Prior to joining the Group in September 2021, Mr. LIU served as the chief technology officer of Hangzhou Weimai Technology Co., Ltd., an internet healthcare and medical company, and worked for Alibaba (NYSE: BABA; HKEX: 9988) for over 10 years, involved in new retail projects including Tmall and Hema. Mr. LIU has extensive experiences in architecture design and research and development of retail platform, middle office of business, data platform and supply chain platform, as well as the design and commercialization of commercial products.

Ms. SHANG Jing, aged 40, is the director, general manager and was one of the founders of Shaanxi Yizhinuo Information Technology Co., Limited, a subsidiary of the Group. She joined the Group as its president, Healthcare Unit (Echartnow) upon the completion of the Company’s acquisition of Shaanxi Yizhinuo Information Technology Co., Limited in April 2021. Ms. SHANG has about 10 years’ experience in sales and marketing in pharmaceutical multinational corporations, including Pfizer and Novartis. Ms. SHANG also serves as director of several subsidiaries of the Company.

Mr. WANG Jian, aged 48, is the director, general manager and was one of the founders of Pingtan Xinban Clinic Company Limited, a subsidiary of the Group. He joined the Group upon the completion of the Company’s acquisition of Pingtan Xinban Clinic Company Limited in April 2021. Mr. WANG holds a bachelor degree in clinical medicine, and has over 25 years’ experience in professional medical practice, management of medical and health technology enterprises, as well as investments and entrepreneurship in the field of medical and health technology. Mr. WANG serves as director of several subsidiaries of the Company.